Gelonghui, May 14, 丨 Tailing Pharmaceutical (01011.HK) announced that the board of directors proposed a “10 in 1” share merger. Stock consolidation is subject to shareholders' approval at a special shareholders' meeting before it can actually take place.
After the share merger comes into effect, it is proposed to change the trading unit for each lot traded on the Stock Exchange from 500 existing shares to 10,000 consolidated shares.